CDKN2A and Miyoshi myopathy: Expectedly, the expression levels of ATP7A, PDHA1, MTF1, and DLST in the MM samples were significantly lower than those in the control group, whereas the levels of FDX1, PDHB, and CDKN2A were significantly higher in the MM samples (Figure 8).